JYNTNasdaqPatent Owners & LessorsFiscal year ends December 31
JOINT Corp
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Aug 7, 2026
$7.27+0.24 (+3.41%)
Close on Oct 19, 2026
- Market cap
- $103.58M
- P/E (TTM)
- 26.9
- Dividend yield
- –
JOINT Corp revenue by segment
By business segment
| Revenue | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 | FY2019 | FY2018 | FY2017 | FY2016 | % of revenue | YoY |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Franchise Operations | $54.90M | $52.16M | $46.98M | $41.83M | $35.66M | $26.93M | $22.64M | $17.12M | $13.79M | $11.97M | 100.0% | +5.2% |
| Corporate clinics | – | – | $70.72M | $59.42M | $44.35M | $31.76M | $25.81M | $19.55M | $11.12M | $8.55M | – | – |
| Operating income | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 | FY2019 | FY2018 | FY2017 | FY2016 | YoY |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Franchise Operations | – | – | $20.33M | $17.34M | $15.35M | $12.56M | $10.97M | $8.08M | $6.09M | $4.56M | – |
| Corporate clinics | – | – | -$2.50M | $110.26K | $6.60M | $4.51M | $3.37M | $1.48M | -$1.70M | -$9.73M | – |
By product or service
| Revenue | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 | FY2019 | FY2018 | FY2017 | FY2016 | % of revenue | YoY |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Royalty fees | $33.20M | $32.14M | $29.16M | $26.19M | $22.06M | $15.89M | $13.56M | $10.14M | $7.72M | – | 60.5% | +3.3% |
| Advertising fund revenue | $10.45M | $9.18M | $8.32M | $7.46M | $6.30M | $4.51M | $3.88M | $2.86M | $2.75M | – | 19.0% | +13.8% |
| Software fees | $6.04M | $5.69M | $5.09M | $4.29M | $3.38M | $2.69M | $1.87M | $1.29M | $1.14M | – | 11.0% | +6.2% |
| Franchise and regional developer | $3.37M | $3.00M | $2.88M | $2.44M | $2.66M | $2.10M | $1.79M | $1.69M | $1.38M | – | 6.1% | +12.5% |
| Other revenues | $1.83M | $2.15M | $1.53M | $2.15M | $1.26M | $861.18K | $740.92K | $535.56K | $398.93K | – | 3.3% | -14.9% |
| Company clinics | – | – | $70.72M | $59.42M | $44.35M | $31.76M | $25.81M | $19.55M | $11.13M | – | – | – |
| Regional developer fees | – | – | – | $0 | $0 | $876.80K | $803.85K | $599.37K | $399.05K | – | – | – |
By region
From the segment and revenue-disaggregation notes of Joint's 10-K and 10-Q filings (XBRL). Fourth-quarter figures are the fiscal year less the first nine months. Segment names follow the company's own labels and can change when it reorganizes.